Search results
AbbVie joins in latest gastrointestinal drug chase
BioPharma Dive via Yahoo Finance· 1 day agoFutureGen could receive up to $1.56 billion in additional fees based on hitting development, regulatory and sales milestones. With FG-M701, AbbVie has a...
Here's How Many Shares Of AbbVie You Would Need To Earn $500 Per Month In Dividends
Benzinga via Yahoo Finance· 2 days agoWith 52 consecutive years of dividend growth and a dividend yield of over 3.6%, AbbVie Inc....
Biogen Inc. (NASDAQ:BIIB) Shares Bought by FIL Ltd
ETF DAILY NEWS· 6 hours agoFIL Ltd raised its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 936.4% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 656,502 shares of ...
Alvotech and STADA to co-develop biosimilars for bone disease treatments
BioPharma-Reporter· 2 days agoDenosumab is designed to block a protein called RANKL, stopping bone cells called osteoclasts from...
AbbVie inks deal to develop new IBD therapy with FutureGen By Investing.com
Investing.com· 2 days agoFG-M701, which is currently in the preclinical development stage, is designed as a fully human...
AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate
Zacks via Yahoo Finance· 24 hours agoAbbVie (ABBV) signs an exclusive global licensing deal with the Chinese company FutureGen to develop...
7 A-Rated Biotech Stocks Worth Betting On in June
InvestorPlace· 1 day agoLet me be clear: investing in biotech stocks isn’t for everyone. Investing in smaller biotech companies requires research, patience, and risk tolerance....
AbbVie inks immune disorder drug licensing deal with China's FutureGen
Reuters via Yahoo News· 2 days agoAbbVie has been counting on its newer immunology medicines to help make up for declining sales of...
Heads Up: Abbvie's Migraine Portfolio 'Very, Very Strong'
MediaPost· 3 days agoIn the wake of Abbvie’s loss of exclusivity for its blockbuster Humira anti-inflammatory drug, its migraine-fighting meds -- Ubrelva, Qulipta and Botox -- have emerged as ...
Shell Asset Management Co. Sells 9,507 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 days agoShell Asset Management Co. cut its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 19.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities ...
